Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid

Dan Ye, Wei Zhou, Tong Lu, Setti G. Jagadeesh, John R. Falck, Hon Chi Lee

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Recently, we reported that 11,12-epoxyeicosatrienoic acid (11,12-EET) potently activates rat mesenteric arterial ATP-sensitive K+ (K ATP) channels and produces significant vasodilation through protein kinase A-dependent mechanisms. In this study, we tried to further delineate the signaling steps involved in the activation of vascular KATP channels by EETs. Whole cell patch-clamp recordings [0.1 mM ATP in the pipette, holding potential (HP) = 0 mV and testing potential (TP) = -100 mV] in freshly isolated rat mesenteric smooth muscle cells showed small glibenclamide-sensitive K ATP currents (19.0 ± 7.9 pA, n = 5) that increased 6.9-fold on exposure to 5 μM 14,15-EET (132.0 ± 29.0 pA, n = 7, P < 0.05 vs. control). With 1 mM ATP in the pipette solution, KATP currents (HP = 0 mV and TP = -100 mV) were increased 3.5-fold on exposure to 1 μM 14,15-EET (57.5 ± 14.3 pA, n = 9, P < 0.05 vs. baseline). In the presence of 100 nM iberiotoxin, 1 μM 14,15-EET hyperpolarized the membrane potential from -20.5 ± 0.9 mV at baseline to -27.1 ± 3.0 mV (n = 6 for both, P < 0.05 vs. baseline), and the EET effects were significantly reversed by 10 μM glibenclamide (-21.8 ± 1.4 mV, n = 6, P < 0.05 vs. EET). Incubation with 5 μM 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE), a 14,15-EET antagonist, abolished the 14,15-EET effects (31.0 ± 11.8 pA, n = 5, P < 0.05 vs. 14,15-EET, P = not significant vs. control). The 14,15-EET effects were inhibited by inclusion of anti-Gsα antibody (1:500 dilution) but not by control IgG in the pipette solution. The effects of 14,15-EET were mimicked by cholera toxin (100 ng/ml), an exogenous ADP-ribosyltransferase. Treatment with the ADP-ribosyltransferase inhibitors 3-aminobenzamide (1 mM) or m-iodobenzylguanidine (100 μM) abrogated the effects of 14,15-EET on KATP currents. These results were corroborated by vasodilation studies. 14,15-EET dose-dependently dilated isolated small mesenteric arteries, and this was significantly attenuated by treatment with 14,15-EEZE or 3-aminobenzamide. These results suggest that 14,15-EET activates vascular KATP channels through ADP-ribosylation of Gsα.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume290
Issue number4
DOIs
StatePublished - Apr 2006

Fingerprint

KATP Channels
Adenosine Triphosphate
ADP Ribose Transferases
Glyburide
Vasodilation
Blood Vessels
14,15-epoxy-5,8,11-eicosatrienoic acid
3-Iodobenzylguanidine
Mesenteric Arteries
Cholera Toxin
Cyclic AMP-Dependent Protein Kinases
Membrane Potentials
Adenosine Diphosphate
Smooth Muscle Myocytes
Anti-Idiotypic Antibodies
Immunoglobulin G

Keywords

  • ADP-ribosylation
  • ATP-sensitive potassium channel
  • Mesenteric artery

ASJC Scopus subject areas

  • Physiology

Cite this

Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid. / Ye, Dan; Zhou, Wei; Lu, Tong; Jagadeesh, Setti G.; Falck, John R.; Lee, Hon Chi.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 290, No. 4, 04.2006.

Research output: Contribution to journalArticle

@article{8caceafcc68c4f429ee76a11b3263d3e,
title = "Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid",
abstract = "Recently, we reported that 11,12-epoxyeicosatrienoic acid (11,12-EET) potently activates rat mesenteric arterial ATP-sensitive K+ (K ATP) channels and produces significant vasodilation through protein kinase A-dependent mechanisms. In this study, we tried to further delineate the signaling steps involved in the activation of vascular KATP channels by EETs. Whole cell patch-clamp recordings [0.1 mM ATP in the pipette, holding potential (HP) = 0 mV and testing potential (TP) = -100 mV] in freshly isolated rat mesenteric smooth muscle cells showed small glibenclamide-sensitive K ATP currents (19.0 ± 7.9 pA, n = 5) that increased 6.9-fold on exposure to 5 μM 14,15-EET (132.0 ± 29.0 pA, n = 7, P < 0.05 vs. control). With 1 mM ATP in the pipette solution, KATP currents (HP = 0 mV and TP = -100 mV) were increased 3.5-fold on exposure to 1 μM 14,15-EET (57.5 ± 14.3 pA, n = 9, P < 0.05 vs. baseline). In the presence of 100 nM iberiotoxin, 1 μM 14,15-EET hyperpolarized the membrane potential from -20.5 ± 0.9 mV at baseline to -27.1 ± 3.0 mV (n = 6 for both, P < 0.05 vs. baseline), and the EET effects were significantly reversed by 10 μM glibenclamide (-21.8 ± 1.4 mV, n = 6, P < 0.05 vs. EET). Incubation with 5 μM 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE), a 14,15-EET antagonist, abolished the 14,15-EET effects (31.0 ± 11.8 pA, n = 5, P < 0.05 vs. 14,15-EET, P = not significant vs. control). The 14,15-EET effects were inhibited by inclusion of anti-Gsα antibody (1:500 dilution) but not by control IgG in the pipette solution. The effects of 14,15-EET were mimicked by cholera toxin (100 ng/ml), an exogenous ADP-ribosyltransferase. Treatment with the ADP-ribosyltransferase inhibitors 3-aminobenzamide (1 mM) or m-iodobenzylguanidine (100 μM) abrogated the effects of 14,15-EET on KATP currents. These results were corroborated by vasodilation studies. 14,15-EET dose-dependently dilated isolated small mesenteric arteries, and this was significantly attenuated by treatment with 14,15-EEZE or 3-aminobenzamide. These results suggest that 14,15-EET activates vascular KATP channels through ADP-ribosylation of Gsα.",
keywords = "ADP-ribosylation, ATP-sensitive potassium channel, Gα, Mesenteric artery",
author = "Dan Ye and Wei Zhou and Tong Lu and Jagadeesh, {Setti G.} and Falck, {John R.} and Lee, {Hon Chi}",
year = "2006",
month = "4",
doi = "10.1152/ajpheart.00318.2005",
language = "English (US)",
volume = "290",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid

AU - Ye, Dan

AU - Zhou, Wei

AU - Lu, Tong

AU - Jagadeesh, Setti G.

AU - Falck, John R.

AU - Lee, Hon Chi

PY - 2006/4

Y1 - 2006/4

N2 - Recently, we reported that 11,12-epoxyeicosatrienoic acid (11,12-EET) potently activates rat mesenteric arterial ATP-sensitive K+ (K ATP) channels and produces significant vasodilation through protein kinase A-dependent mechanisms. In this study, we tried to further delineate the signaling steps involved in the activation of vascular KATP channels by EETs. Whole cell patch-clamp recordings [0.1 mM ATP in the pipette, holding potential (HP) = 0 mV and testing potential (TP) = -100 mV] in freshly isolated rat mesenteric smooth muscle cells showed small glibenclamide-sensitive K ATP currents (19.0 ± 7.9 pA, n = 5) that increased 6.9-fold on exposure to 5 μM 14,15-EET (132.0 ± 29.0 pA, n = 7, P < 0.05 vs. control). With 1 mM ATP in the pipette solution, KATP currents (HP = 0 mV and TP = -100 mV) were increased 3.5-fold on exposure to 1 μM 14,15-EET (57.5 ± 14.3 pA, n = 9, P < 0.05 vs. baseline). In the presence of 100 nM iberiotoxin, 1 μM 14,15-EET hyperpolarized the membrane potential from -20.5 ± 0.9 mV at baseline to -27.1 ± 3.0 mV (n = 6 for both, P < 0.05 vs. baseline), and the EET effects were significantly reversed by 10 μM glibenclamide (-21.8 ± 1.4 mV, n = 6, P < 0.05 vs. EET). Incubation with 5 μM 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE), a 14,15-EET antagonist, abolished the 14,15-EET effects (31.0 ± 11.8 pA, n = 5, P < 0.05 vs. 14,15-EET, P = not significant vs. control). The 14,15-EET effects were inhibited by inclusion of anti-Gsα antibody (1:500 dilution) but not by control IgG in the pipette solution. The effects of 14,15-EET were mimicked by cholera toxin (100 ng/ml), an exogenous ADP-ribosyltransferase. Treatment with the ADP-ribosyltransferase inhibitors 3-aminobenzamide (1 mM) or m-iodobenzylguanidine (100 μM) abrogated the effects of 14,15-EET on KATP currents. These results were corroborated by vasodilation studies. 14,15-EET dose-dependently dilated isolated small mesenteric arteries, and this was significantly attenuated by treatment with 14,15-EEZE or 3-aminobenzamide. These results suggest that 14,15-EET activates vascular KATP channels through ADP-ribosylation of Gsα.

AB - Recently, we reported that 11,12-epoxyeicosatrienoic acid (11,12-EET) potently activates rat mesenteric arterial ATP-sensitive K+ (K ATP) channels and produces significant vasodilation through protein kinase A-dependent mechanisms. In this study, we tried to further delineate the signaling steps involved in the activation of vascular KATP channels by EETs. Whole cell patch-clamp recordings [0.1 mM ATP in the pipette, holding potential (HP) = 0 mV and testing potential (TP) = -100 mV] in freshly isolated rat mesenteric smooth muscle cells showed small glibenclamide-sensitive K ATP currents (19.0 ± 7.9 pA, n = 5) that increased 6.9-fold on exposure to 5 μM 14,15-EET (132.0 ± 29.0 pA, n = 7, P < 0.05 vs. control). With 1 mM ATP in the pipette solution, KATP currents (HP = 0 mV and TP = -100 mV) were increased 3.5-fold on exposure to 1 μM 14,15-EET (57.5 ± 14.3 pA, n = 9, P < 0.05 vs. baseline). In the presence of 100 nM iberiotoxin, 1 μM 14,15-EET hyperpolarized the membrane potential from -20.5 ± 0.9 mV at baseline to -27.1 ± 3.0 mV (n = 6 for both, P < 0.05 vs. baseline), and the EET effects were significantly reversed by 10 μM glibenclamide (-21.8 ± 1.4 mV, n = 6, P < 0.05 vs. EET). Incubation with 5 μM 14,15-epoxyeicosa-5(Z)-enoic acid (14,15-EEZE), a 14,15-EET antagonist, abolished the 14,15-EET effects (31.0 ± 11.8 pA, n = 5, P < 0.05 vs. 14,15-EET, P = not significant vs. control). The 14,15-EET effects were inhibited by inclusion of anti-Gsα antibody (1:500 dilution) but not by control IgG in the pipette solution. The effects of 14,15-EET were mimicked by cholera toxin (100 ng/ml), an exogenous ADP-ribosyltransferase. Treatment with the ADP-ribosyltransferase inhibitors 3-aminobenzamide (1 mM) or m-iodobenzylguanidine (100 μM) abrogated the effects of 14,15-EET on KATP currents. These results were corroborated by vasodilation studies. 14,15-EET dose-dependently dilated isolated small mesenteric arteries, and this was significantly attenuated by treatment with 14,15-EEZE or 3-aminobenzamide. These results suggest that 14,15-EET activates vascular KATP channels through ADP-ribosylation of Gsα.

KW - ADP-ribosylation

KW - ATP-sensitive potassium channel

KW - Gα

KW - Mesenteric artery

UR - http://www.scopus.com/inward/record.url?scp=33646108134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646108134&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00318.2005

DO - 10.1152/ajpheart.00318.2005

M3 - Article

C2 - 16537788

AN - SCOPUS:33646108134

VL - 290

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 4

ER -